ClinicalTrials.Veeva

Menu

Cauterization Versus fibrin Glue for Conjunctival Autografting in Primary Pterygium Surgery

U

University of Split

Status

Enrolling

Conditions

Pterygium of Conjunctiva and Cornea

Treatments

Procedure: Cauterization
Procedure: Fibrin glue

Study type

Interventional

Funder types

Other

Identifiers

NCT03321201
PTERYGIUM1

Details and patient eligibility

About

Pterygium is a noncancerous growth of the conjunctival tissue over the cornea. It is a progressive disease that may lead to visual impairment in advanced stages, as well as restriction of ocular motility, chronic inflammation and cosmetic concerns. Surgical removal is the treatment of choice, but recurrence of pterygium is a frequent problem. In this randomized controlled cauterization will be compared with fibrin glue for conjunctival autografting in primary pterygium surgery.

Enrollment

164 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • adults (older than 18 years of age)
  • both sexes
  • primary nasal pterygia ˃4 mm, which tends to increase, including patients with reduced visual acuity, chronic inflammation, cosmetic reasons
  • if the patients had a bilateral pterygium, only one eye will be operated

Exclusion criteria

  • connective tissue disease
  • prior eye surgery
  • chronic use of topical drugs (anti-glaucoma drugs)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

164 participants in 2 patient groups

Cauterization
Experimental group
Treatment:
Procedure: Cauterization
Fibrin glue
Active Comparator group
Treatment:
Procedure: Fibrin glue

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems